Navigation Links
Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries

Diflucan Partnership seems to be the latest mantra of Pfizer. The pharmaceutical giant has announced that it will supply free antifungal drug to 50 countries hardest hit by the AIDS virus. The decision by the Pfizer comes close on the heels of the South African Government winning a landmark case against pharmaceutical companies. In an announcement on Wednesday Pfizer said AIDS related antifungal drug Diflucan will be given free of cost to battle HIV through a programe to be coordinated by World Health Organization and the United Nations.

"Together with our partners in the United Nations and the WHO, we now have a framework to offer Diflucan to the least-developed nations targeted by the UN and the WHO as the most affected by the AIDS crisis", Dr.Henry McKinnell, CEO of Pfizer, told reporters at a press conference.

Many patients stricken with AIDS develop complication of fungal origin. Two common conditions are esophageal candidiasis and cryptococcal meningitis. Flucanazole, commerically available as Diflucan is used to treat these conditions.

Representatives of Pfizer Inc. said they do not know how much the expanded 50-nation program would cost. However, they said that expenses of the project, called the Diflucan Partnership, would include drug manufacturing, shipping, transportation, medical training and patient education.
'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Medicis Pharmaceutical company enters pediatric market
3. Pharmaceutical companies are targeting patients
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
7. Pharmaceutical industries grant for R&D to be monitored
8. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
9. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Top Pharmaceuticals Influence Doctors Prescriptions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern Georgie ... Foundation in a community wide charity event with the goal of bringing in support ... local woman who lives with epilepsy, recently launched a charity campaign of her own ...
(Date:7/21/2017)... ... July 21, 2017 , ... Thomas Jefferson University , ... was awarded a $300,000 grant from The Pew Center for Arts & Heritage ... and the recognition of one’s own limits among health professions students. , ...
(Date:7/21/2017)... NJ (PRWEB) , ... July 21, 2017 , ... ... has received a $5,000 grant from the C. R. Bard Foundation, ... Day Center at Somerset Hills , a service available through the nonprofit home ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) ... of life a decade after surgery, though activity levels decline over time. The ...
(Date:7/20/2017)... MA (PRWEB) , ... July 20, 2017 , ... ... form of blood and bone marrow cancer that progresses rapidly without treatment. Newly ... recommended to reduce the chance of reoccurrence and relapse. With such a ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
(Date:7/10/2017)... N.C. , July 10, 2017 Locus ... Convertible Note to support the development of CRISPR-Cas3 antimicrobial ... Holdings Limited, a leading Chinese Internet services provider, and ... will advance multiple infectious disease product programs targeting antibiotic ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... July 5, 2017 Wolfmet 3D  printed tungsten collimator manufactured ... physics and manufacturing combine to progress molecular radiotherapy imaging. ... systems are unable to accurately quantify the radiation absorbed by ... regarding the success of this radiotherapy treatment has been available ... ...
Breaking Medicine Technology: